LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 92.98 | 84.90 | 5289 | 7257 | 0.7288 | 0.9038 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 94.68 | 84.90 | 3891 | 7000 | 0.5558 | 0.8237 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 94.68 | 84.90 | 5826 | 7000 | 0.8322 | 0.9431 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 94.68 | 84.90 | 4030 | 7000 | 0.5757 | 0.8338 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 94.68 | 84.90 | 5382 | 7000 | 0.7688 | 0.9191 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.66 | 84.90 | 486 | 285 | 1.7009 | 1.7088 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 2.66 | 84.90 | 631 | 285 | 2.2083 | 2.1444 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.36 | 84.90 | 2 | 322 | 0.0062 | -0.8572 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.36 | 84.90 | 599 | 322 | 1.8570 | 1.7581 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.36 | 84.90 | 770 | 322 | 2.3871 | 2.1422 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.06 | 84.90 | 2 | 365 | 0.0055 | -0.8313 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.06 | 84.90 | 694 | 365 | 1.8990 | 1.7120 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.06 | 84.90 | 832 | 365 | 2.2766 | 1.9559 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.77 | 84.90 | 777 | 411 | 1.8894 | 1.6450 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.77 | 84.90 | 924 | 411 | 2.2469 | 1.8542 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 9.47 | 84.90 | 3 | 447 | 0.0067 | -0.7519 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 9.47 | 84.90 | 846 | 447 | 1.8908 | 1.6086 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 9.47 | 84.90 | 982 | 447 | 2.1948 | 1.7759 | MN20160318_Q02 | K11 |